Showing results (111-120 of 406) with videos related to
Sort By:
Pageof 41
Arthritis and Rheumatism|May 15, 2003
Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosusAnnett M Jacobi, Marcus Odendahl, Karin Reiter, et al.Rheumatology and Therapy|December 6, 2021
Clinical Management of Herpes Zoster in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Receiving Tofacitinib TreatmentKevin L Winthrop, Jeffrey R Curtis, Kunihiro Yamaoka, et al.Diagnostics (Basel, Switzerland)|January 8, 2023
Performance of Deauville Criteria in [18F]FDG-PET/CT Diagnostics of Giant Cell ArteritisJeffrey Siefert, Jonas Kaufmann, Felix Thiele, et al.BMJ Open|August 4, 2021
Is the fluorescence optical imaging (FOI) able to discriminate between rheumatoid arthritis patients with and without need of rituximab retherapy? A cohort studySchahrasad Lisa Ridha Ali, Anne-Marie Glimm, Gerd R Burmester, et al.Annals of the Rheumatic Diseases|March 11, 2016
The changing landscape of biosimilars in rheumatologyThomas Dörner, Vibeke Strand, Paul Cornes, et al.Arthritis Research & Therapy|November 12, 2014
Active systemic lupus erythematosus is associated with a reduced cytokine production by B cells in response to TLR9 stimulationJulia Sieber, Capucine Daridon, Sarah J Fleischer, et al.Journal of Clinical Pharmacology|September 8, 2016
Pharmacokinetic and Pharmacodynamic Analysis of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis From 2 Randomized, Controlled Trials: SUMMACTA and BREVACTAHisham Abdallah, Joy C Hsu, Peng Lu, et al.RMD Open|June 3, 2025
Benefit-risk analysis of upadacitinib versus adalimumab in patients with rheumatoid arthritis and higher or lower risk of cardiovascular diseaseGerd R Burmester, Eduardo Mysler, Peter Taylor, et al.European Journal of Immunology|July 7, 2018
Proteasome inhibition with bortezomib induces a therapeutically relevant depletion of plasma cells in SLE but does not target their precursorsTobias Alexander, Qingyu Cheng, Jens Klotsche, et al.Annals of the Rheumatic Diseases|March 12, 2018
Common language description of the term rheumatic and musculoskeletal diseases (RMDs) for use in communication with the lay public, healthcare providers and other stakeholders endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR)Désirée van der Heijde, David I Daikh, Neil Betteridge, et al.Pageof 41